TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nobel Biocare AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
426,637
|
376,622
|
357,850 |
Financial expenses |
9,966
|
19,101
|
12,235 |
Earnings before taxes |
18,580
|
22,807
|
9,086 |
EBITDA |
54,863
|
67,491
|
40,132 |
Total assets |
1,131,739
|
948,609
|
1,692,231 |
Current assets |
464,508
|
256,678
|
933,773 |
Current liabilities |
304,070
|
142,111
|
833,852 |
Equity capital |
816,517
|
797,562
|
848,598 |
- share capital |
213,046
|
211,954
|
230,636 |
Employees (average) |
345
|
364
|
350 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.1%
|
84.1%
|
50.1% |
Turnover per employee |
1,237
|
1,035
|
1,022 |
Profit as a percentage of turnover |
4.4%
|
6.1%
|
2.5% |
Return on assets (ROA) |
2.5%
|
4.4%
|
1.3% |
Current ratio |
152.8%
|
180.6%
|
112.0% |
Return on equity (ROE) |
2.3%
|
2.9%
|
1.1% |
Change turnover |
48,075
|
47,758
|
96,688 |
Change turnover % |
13%
|
15%
|
37% |
Chg. No. of employees |
-19
|
14
|
54 |
Chg. No. of employees % |
-5%
|
4%
|
18% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.